Larson Financial Group’s Roivant Sciences ROIV Stock Holding History

Larson Financial Group’s Portfolio ROIV Stock Details ROIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$28.4K	Buy	802 +1	+0.1%	+$30	﹤0.01%	1811
2026 Q1	$22.2K	Hold	801	–	–	﹤0.01%	1787
2025 Q4	$17.4K	Buy	801 +23	+3%	+$454	﹤0.01%	1797
2025 Q3	$11.8K	Buy	778 +177	+29%	+$2.19K	﹤0.01%	1932
2025 Q2	$6.77K	Buy	601 +575	+2,212%	+$6.23K	﹤0.01%	1972
2025 Q1	$262	Buy	26 +1	+4%	+$11	﹤0.01%	2732
2024 Q4	$296	Hold	25	–	–	﹤0.01%	2340
2024 Q3	$289	Buy	+25	New	+$285	﹤0.01%	2263

Other funds holding ROIV

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Larson Financial Group's ROIV Position: Q2 2026 in Review

Larson Financial Group increased its Roivant Sciences (ROIV) stake by 0.12% in Q2 2026, buying an estimated $30 and bringing the position to 802 shares worth $28.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1811.

Larson Financial Group first reported a position in ROIV in Q3 2024 and has held it in 8 quarters since. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

Larson Financial Group held 802 shares of Roivant Sciences worth $28.4K as of Q2 2026.
Larson Financial Group bought 1 Roivant Sciences share in Q2 2026, an estimated $30.
Roivant Sciences made up ﹤0.01% of Larson Financial Group's portfolio in Q2 2026, its #1811 holding.
Larson Financial Group first reported a position in Roivant Sciences in Q3 2024 and has held it in 8 quarters since.
498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Larson Financial Group's 13F filing for Q2 2026, filed 14 Aug 2026.